September 19, 2014 8:56 AM ET


Company Overview of Genomatica, Inc.

Company Overview

Genomatica, Inc. delivers manufacturing processes to produce intermediate and basic chemicals from renewable feedstocks. The company’s proprietary biotechnology platform allows the company to create fermentation-based manufacturing processes and to engineer the enabling microorganisms that drive the conversion of renewable feedstocks into intermediate and basic chemicals. It is developing a pipeline of manufacturing processes for the production of 20 intermediate and basic chemicals, including butanediol and butadiene. The company intends to offer its chemical products to large consumer products or chemical companies. Genomatica, Inc. was founded in 1998 and is headquartered in San Diego, Ca...

4757 Nexus Center Drive

San Diego, CA 92121

United States

Founded in 1998

88 Employees





Key Executives for Genomatica, Inc.

Age: 40
Executive Chairman
Age: 69
Co-Founder and Chairman of Scientific Advisory Board
Executive Vice President and Chief Financial Officer
Age: 58
Vice President of Operations
Age: 61
Compensation as of Fiscal Year 2014.

Genomatica, Inc. Key Developments

Genomatica, Inc. Presents at Jefferies 2014 Global Industrials Conference, Aug-12-2014 04:30 PM

Genomatica, Inc. Presents at Jefferies 2014 Global Industrials Conference, Aug-12-2014 04:30 PM. Venue: Grand Hyatt, 109 E. 42nd St., New York, New York, United States. Speakers: Christophe H. Schilling, Co-Founder, Chief Executive Officer, President, Chief Scientific officer and Director.

Genomatica, Inc. Presents at World Congress on Industrial Biotechnology, May-12-2014

Genomatica, Inc. Presents at World Congress on Industrial Biotechnology, May-12-2014 . Venue: Philadelphia, Pennsylvania, United States.

Genomatica Appoints Kaspar Evertz as Executive Vice President, Commercial

Genomatica announced the appointment of Kaspar Evertz, Ph.D., as Executive Vice President, Commercial. Evertz will lead the company’s business development, licensing, and technology transfer teams with a focus on licensing its process technologies, and the delivery and execution of those licenses. He also will be responsible for securing strategic partners to support the development of additional commercial processes through sponsored development programs. Evertz brings 24 years of major chemical industry experience, particularly in licensing. Evertz joins Genomatica from Ferrostaal AG, where he was executive vice president and managing director of industrial projects. Genomatica’s current Chief Business Development Officer, William H. Baum, will transition to a part-time role, where he will focus on special projects and continue his role on the company’s Board of Directors, where he has been a member since 2006.

Similar Private Companies By Industry

Company Name Region
Haywood Company United States
PenCell Plastics Inc. United States
Durable Products, Inc. United States
MedPlast, Inc. United States
Nycon Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Genomatica, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at